Up to 50% of cancer patients suffer from a progressive atrophy of adipose tissue and skeletal
muscle, called cachexia, resulting in weight loss, a reduced quality of life, and a shortened …

Cachexia — the massive (up to 80%) loss of both adipose tissue and skeletal muscle mass
— is a significant factor in the poor performance status and high mortality rate of cancer …

About half of all cancer patients show a syndrome of cachexia, characterized by loss of
adipose tissue and skeletal muscle mass. Such patients have a decreased survival time, …

Aim: N-3 fatty acids, especially eicosapentaenoic acid (EPA), may possess anticachectic
properties. This trial compared a protein and energy dense supplement enriched with n-3 fatty …

Previous studies have suggested that administration of oral eicosapentaenoic acid (EPA) will
stabilize weight in patients with advanced pancreatic cancer. The aim of the present study …

Resistant variants of human immunodeficiency virus type 1 (HIV-1) have been selected by
limited passage in MT4 cells of both wild-type and 3'-azido-3'-deoxythymidine (AZT, …

1592U89, (-)-(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclo pentene-1-methanol,
is a carbocyclic nucleoside with a unique biological profile giving potent, selective …

Background: The antiviral effect of anti-influenza drugs such as zanamivir may be demonstrated
in patients as an increased rate of decline in viral load over a time course of treatment …

… degycosylation kit; lane 4, treatment with 2 M NaBH, in 0.1 M NaOH at 37 C for 16 h; lane 5,
… A mocktreated control showed no change in M. METHODS. Hybridomas were produced by …

Atrophy of skeletal muscle is common in patients with cancer and results in increased morbidity
and mortality. In order to design effective therapy the mechanism by which this occurs …